Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
RESILIENCE has expanded the spectrum of patients who can enter its clinical trial. Thus, those people with breast cancer being treated with anthracyclines who meet the criteria assessed by their oncologists may be eligible to participate in the trial. The remote ischemic conditioning (RIC) to which these cancer patients will have access within the RESILIENCE […]
